EVOGENE LTD.
EVGNStock
$0.58−54.01%52W
Market Cap$6.99M
P/E—
Div yield—
Beta1.38
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-58.63%
Price vs S&P 500 (4W)2.88%
VGM Score50.88
Market Capitalization$6.99M
Earnings Surprise History
Q1 26-0.60est. -0.28
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.14
4.14
4.14
4.14
Industry Peers — Agricultural Chemicals(11)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
EVGNEVOGENE LTD. | C | B | D | $0.58 |
| NTRNutrien Ltd. Common Shares | B | B | C | $67.10 |
| ICLICL Group Ltd. | B | C | C | $5.04 |
| CFCF Industries Holding, Inc. | B | B | B | $118.66 |
| MOSThe Mosaic Company | B | C | C | $22.53 |
| SMGThe Scotts Miracle-Gro Company | B | D | B | $73.47 |
| UANCVR Partners, LP | B | B | C | $118.79 |
| CBUSCibus, Inc. Class A Common Stock | D | D | A | $1.81 |
| AVDAmerican Vanguard Corporation | B | C | C | $2.69 |
| BIOXBioceres Crop Solutions Corp. Ordinary Shares | A | C | D | $0.35 |
| FRTTFort Technology Inc. Common Shares | — | — | D | $0.90 |
About
Evogene Ltd is a computational biology company that uses its Computational Predictive Biology platform to discover and develop life-science products based on microbes, small molecules, and genetic elements. The company operates across three sectors—agriculture, human health, and industrial applications—through a portfolio of subsidiaries developing agricultural biologicals, seed traits, microbiome therapeutics, and specialty chemicals. Revenue is generated primarily from the agriculture segment.